Richard C. Josiassen - Publications

Affiliations: 
Psychiatry Drexel University College of Medicine, Philadelphia, PA, United States 
Area:
Schizophrenia, neuroscience, neurophysiology

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Farrell M, Lichtenstein M, Crowley J, Filmyer D, Lázaro-Muñoz G, Shaughnessy R, Mackenzie IR, Hirsch-Reinshagen V, Stowe R, Evans J, Berg J, Szatkiewicz J, Josiassen R, Sullivan PF. THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1006-S1007. DOI: 10.1016/J.Euroneuro.2017.08.401  0.353
2017 Josiassen RC, Filmyer DM, Gillean J, Shah SS, Dietterich TE, Shaughnessy RA. Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient's Perspective. The American Journal of Case Reports. 18: 1185-1189. PMID 29114100 DOI: 10.12659/Ajcr.906454  0.301
2017 Kane J, Josiassen R, Burke J, Jimenez R, Siegert S, Liang G. SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia Schizophrenia Bulletin. 43: S119-S119. DOI: 10.1093/Schbul/Sbx023.016  0.348
2012 Geboy AG, Filmyer DM, Josiassen RC. Motor deficits associated with mild, chronic hyponatremia: a factor analytic study. Journal of Motor Behavior. 44: 255-9. PMID 22671716 DOI: 10.1080/00222895.2012.688895  0.33
2012 Josiassen RC, Curtis JL, Shaughnessy RA, Filmyer DM, Geboy AG, Skuban N, Ouyang J, Czerwiec F. Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients. Clinical Schizophrenia & Related Psychoses. 6: 21-6. PMID 22453866 DOI: 10.3371/Csrp.6.1.3  0.333
2012 Josiassen RC, Filmyer DM, Geboy AG, Martin DM, Curtis JL, Shaughnessy RA, Salzman A, Orlandi C. Psychomotor deficits associated with hyponatremia: a retrospective analysis. The Clinical Neuropsychologist. 26: 74-87. PMID 22087848 DOI: 10.1080/13854046.2011.628697  0.336
2010 Josiassen RC, Shaughnessy RA, Filymer DM, Donohue AM, Kacso M, Finkel N, Curtis J, Audino B, Skuban N. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study. Early Intervention in Psychiatry. 4: 57-63. PMID 20199481 DOI: 10.1111/J.1751-7893.2010.00163.X  0.349
2010 Josiassen RC, Curtis J, Filmyer DM, Audino B, Skuban N, Shaughnessy RA. Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders. Expert Opinion On Pharmacotherapy. 11: 637-48. PMID 20163274 DOI: 10.1517/14656561003610656  0.331
2009 Josiassen RC, Filmyer DM, Curtis JL, Shaughnessy RA, Joseph A, Parson RL, Kacso M, Fedde J, Cornelius MD, Joseph M, Weinstein J, Skuban N, Victor T. An archival, follow-forward exploration of the metabolic syndrome in randomly selected, clozapine-treated patients Clinical Schizophrenia and Related Psychoses. 3: 87-96. DOI: 10.3371/Csrp.3.2.3  0.326
2008 Josiassen RC, Goldman M, Jessani M, Shaughnessy RA, Albazzaz A, Lee J, Ouyang J, Orlandi C, Czerwiec F. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biological Psychiatry. 64: 1097-100. PMID 18692175 DOI: 10.1016/J.Biopsych.2008.06.017  0.369
2008 Josiassen R, Skuban N, Kacso M, Filmyer D, Davis M, Shaughnessy R, Curtis J, Cornelius M. EARLY EFFECTS OF CLOZAPINE TREATMENT ON THE GLUCOSE-INSULINHOMEOSTASIS IN PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 102: 237-238. DOI: 10.1016/S0920-9964(08)70716-3  0.313
2006 Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology. 188: 281-92. PMID 16953381 DOI: 10.1007/S00213-006-0541-X  0.365
2005 Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. The American Journal of Psychiatry. 162: 130-6. PMID 15625211 DOI: 10.1176/Appi.Ajp.162.1.130  0.348
2005 Citrome L, Josiassen R, Bark N, Salazar DE, Mallikaarjun S. Pharmacokinetics of aripiprazole and concomitant lithium and valproate. Journal of Clinical Pharmacology. 45: 89-93. PMID 15601809 DOI: 10.1177/0091270004269870  0.318
2004 Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, Josiassen RC. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. The Journal of Clinical Psychiatry. 65: 1491-8. PMID 15554761 DOI: 10.4088/Jcp.V65N1108  0.361
2003 de Leon J, Odom-White A, Josiassen RC, Diaz FJ, Cooper TB, Simpson GM. Serum antimuscarinic activity during clozapine treatment. Journal of Clinical Psychopharmacology. 23: 336-41. PMID 12920408 DOI: 10.1097/01.Jcp.0000085405.08426.73  0.301
2001 Tracy JI, Monaco C, Giovannetti T, Abraham G, Josiassen RC. Anticholinergicity and cognitive processing in chronic schizophrenia. Biological Psychology. 56: 1-22. PMID 11240312 DOI: 10.1016/S0301-0511(00)00083-1  0.344
1999 Nair CJ, Josiassen RC, Abraham G, Stanilla JK, Tracy JI, Simpson GM. Does akathisia influence psychopathology in psychotic patients treated with clozapine? Biological Psychiatry. 45: 1376-83. PMID 10349044 DOI: 10.1016/S0006-3223(98)00146-2  0.33
1998 Tracy JI, Monaco CA, Abraham G, Josiassen RC, Pollock BG. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone. The Journal of Clinical Psychiatry. 59: 184-8. PMID 9590669 DOI: 10.4088/Jcp.V59N0407  0.363
1997 Abraham G, Nair C, Tracy JI, Simpson GM, Josiassen RC. The effects of clozapine on symptom clusters in treatment-refractory patients. Journal of Clinical Psychopharmacology. 17: 49-53. PMID 9004057 DOI: 10.1097/00004714-199702000-00009  0.358
1997 Abraham G, Tracy JI, Stanilla JK, Verghese C, Simpson GM, Josiassen RC. The relationship of extrapyramidal symptoms and schizophrenia psychopathology Schizophrenia Research. 24: 263. DOI: 10.1016/S0920-9964(97)82755-7  0.382
1996 Tracy JI, De Leon J, Doonan R, Musciente J, Ballas T, Josiassen RC. Clock drawing in schizophrenia. Psychological Reports. 79: 923-8. PMID 8969101 DOI: 10.2466/Pr0.1996.79.3.923  0.355
1996 Tracy JI, McGrory AC, Josiassen RC, Monaco CA. A comparison of reading and demographic-based estimates of premorbid intelligence in schizophrenia. Schizophrenia Research. 22: 103-9. PMID 8958593 DOI: 10.1016/S0920-9964(96)00058-8  0.357
1996 Verghese C, de Leon J, Josiassen RC. Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophrenia Bulletin. 22: 455-64. PMID 8873296 DOI: 10.1093/Schbul/22.3.455  0.317
1996 Josiassen RC, Schindler B. Medical comorbidity and schizophrenia: editors' introduction. Schizophrenia Bulletin. 22: 411-2. PMID 8873292 DOI: 10.1093/Schbul/22.3.411  0.323
1996 Guterman Y, Josiassen RC, Bashore TE, Johnson M, Lubow RE. Latent inhibition effects reflected in event-related brain potentials in healthy controls and schizophrenics. Schizophrenia Research. 20: 315-26. PMID 8827859 DOI: 10.1016/0920-9964(95)00086-0  0.376
1996 Nair C, Abraham G, Leon Jd, Stanilla JK, Josiassen RC, Simpson G. Dose-related effects of clozapine on tardive dyskinesia among “treatment-refractory” patients with schizophrenia Biological Psychiatry. 39: 529-530. DOI: 10.1016/0006-3223(96)84052-2  0.328
1995 Tracy JI, Oesterling R, Josiassen RC. Transient fluctuations in cognitive functioning in schizophrenia based on single-case study methods. Schizophrenia Research. 17: 201-9. PMID 8562495 DOI: 10.1016/0920-9964(94)00086-N  0.324
1995 Tracy JI, McGrory AE, Josiassen RC. Selective attention asymmetries in schizophrenia Schizophrenia Research. 15: 137. DOI: 10.1016/0920-9964(95)95425-9  0.301
1995 Tracy JI, Josiassen RC, Bellack AS. Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders Clinical Psychology Review. 15: 67-97. DOI: 10.1016/0272-7358(95)00001-6  0.329
1994 de Leon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biological Psychiatry. 35: 408-19. PMID 8018788 DOI: 10.1016/0006-3223(94)90008-6  0.301
1994 Guterman Y, Josiassen RC. Sensory gating deviance in schizophrenia in the context of task related effects. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 18: 1-12. PMID 7876034 DOI: 10.1016/0167-8760(84)90010-2  0.374
1994 Tracy J, Eby L, de Leon J, Doonan R, Ballas T, Josiassen R. The stability and agreement of general impairment indicators in schizophrenia Biological Psychiatry. 35: 637. DOI: 10.1016/0006-3223(94)90739-0  0.31
1994 Cloud BS, White AO, Tracy J, Oesterling R, Leon Jd, Josiassen R, Simpson G. The effects of chronic psychosis on rivermead behavioral memory test performance Biological Psychiatry. 35: 637. DOI: 10.1016/0006-3223(94)90738-2  0.334
1992 Guterman Y, Josiassen RC, Bashore TR. Attentional influence on the P50 component of the auditory event-related brain potential. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 12: 197-209. PMID 1592673 DOI: 10.1016/0167-8760(92)90011-Y  0.345
1990 Josiassen RC, Roemer RA, Johnson MM, Shagass C. Are gender differences in schizophrenia reflected in brain event-related potentials? Schizophrenia Bulletin. 16: 229-46. PMID 2374882 DOI: 10.1093/Schbul/16.2.229  0.754
1990 Roemer RA, Josiassen RC, Shagass C. Comparing principal components analyses of evoked potentials recorded from heterogeneous groups of subjects. Psychophysiology. 27: 101-10. PMID 2339183 DOI: 10.1111/J.1469-8986.1990.Tb02187.X  0.71
1990 Josiassen RC, Shagass C, Roemer RA, Slepner S, Czartorysky B. Early cognitive components of somatosensory event-related potentials. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 9: 139-49. PMID 2228748 DOI: 10.1016/0167-8760(90)90068-O  0.723
1988 Josiassen RC, Shagass C, Roemer RA. Somatosensory evoked potential correlates of schizophrenic subtypes identified by the Millon Clinical Multiaxial Inventory. Psychiatry Research. 23: 209-19. PMID 3363029 DOI: 10.1016/0165-1781(88)90011-X  0.714
1988 Josiassen RC, Shagass C, Roemer RA. Dealing with differential gender and age effects in evoked potential studies of psychopathology. Biological Psychiatry. 23: 612-27. PMID 3355878 DOI: 10.1016/0006-3223(88)90008-X  0.702
1988 Josiassen RC, Shagass C, Roemer RA, Slepner S. Evoked potential correlates of intelligence in nonpatient subjects. Biological Psychology. 27: 207-25. PMID 3254727 DOI: 10.1016/0301-0511(88)90031-2  0.73
1988 Josiassen RC, Johnson MM. Age, gender and ERPs in schizophrenia. Let's at least handle the easy ones. Schizophrenia Research. 1: 365-7. PMID 3154524 DOI: 10.1016/0920-9964(88)90051-5  0.326
1988 Josiassen RC, Shagass C, Roemer RA, Mancall E. A sensory evoked potential comparison of persons 'at risk' for Huntington's disease and hospitalized neurotic patients. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 6: 281-9. PMID 2976064 DOI: 10.1016/0167-8760(88)90015-3  0.735
1988 Shagass C, Roemer RA, Josiassen RC. Some quantitative EEG findings in unmedicated and medicated major depressives. Neuropsychobiology. 19: 169-75. PMID 2907777 DOI: 10.1159/000118455  0.706
1988 Galzigna L, Fasolato C, Bianchi M, Burlina AP, Preview A, Jacqmin P, Ansseau M, Shagass C, Roemer RA, Josiassen RC, Vieweg WVR, Godleski LS, Pavalonis DL, Hundley PL, Yank GR, et al. Subject Index Vol. 19, 1988 Neuropsychobiology. 19: 218-219. DOI: 10.1159/000118464  0.596
1988 Galzigna L, Fasolato C, Bianchi M, Burlina AP, Preview A, Jacqmin P, Ansseau M, Shagass C, Roemer RA, Josiassen RC, Vieweg WVR, Godleski LS, Pavalonis DL, Hundley PL, Yank GR, et al. Contents, Vol. 19, 1988 Neuropsychobiology. 19. DOI: 10.1159/000118454  0.539
1988 Shagass C, Josiassen RC, Roemer RA. Psychiatric diagnostic differentiations by evoked potential measures: Results of a second series Research Communications in Psychology, Psychiatry and Behavior. 13: 43-75.  0.69
1986 Josiassen RC, Curry LM, Mancall EL, Shagass C, Roemer RA. Relationship between evoked potential and neuropsychological findings in persons "at risk" for Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 8: 21-36. PMID 2935556 DOI: 10.1080/01688638608401294  0.716
1985 Josiassen RC, Shagass C, Roemer RA, Straumanis JJ. Attention-related effects on somatosensory evoked potentials in college students at high risk for psychopathology. Journal of Abnormal Psychology. 94: 507-18. PMID 4078154 DOI: 10.1037//0021-843X.94.4.507  0.761
1985 Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Combinations of evoked potential amplitude measurements in relation to psychiatric diagnosis. Biological Psychiatry. 20: 701-22. PMID 4005332 DOI: 10.1016/0006-3223(85)90150-7  0.734
1984 Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Psychiatric diagnostic discriminations with combinations of quantitative EEG variables. The British Journal of Psychiatry : the Journal of Mental Science. 144: 581-92. PMID 6743925 DOI: 10.1192/Bjp.144.6.581  0.715
1984 Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Distinctive somatosensory evoked potential features in obsessive-compulsive disorder. Biological Psychiatry. 19: 1507-24. PMID 6518205  0.733
1984 Josiassen RC, Shagass C, Mancall EL, Roemer RA. Auditory and visual evoked potentials in Huntington's disease. Electroencephalography and Clinical Neurophysiology. 57: 113-8. PMID 6198151 DOI: 10.1016/0013-4694(84)90169-X  0.745
1984 Josiassen RC, Shagass C, Straumanis JJ, Roemer RA. Psychiatric drugs and the somatosensory P400 wave. Psychiatry Research. 11: 151-62. PMID 6143336 DOI: 10.1016/0165-1781(84)90099-4  0.738
1983 Shagass C, Josiassen RC, Roemer RA, Straumanis JJ, Slepner SM. Failure to replicate evoked potential observations suggesting corpus callosum dysfunction in schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 142: 471-6. PMID 6871561 DOI: 10.1192/Bjp.142.5.471  0.72
1983 Roemer RA, Shagass C, Josiassen RC, Straumanis JJ, Slepner SM. Rheoencephalographic concomitants of cognitive engagement in nonpatients and schizophrenics. An exploratory study. Human Neurobiology. 2: 97-102. PMID 6629879  0.668
1983 Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Archives of Neurology. 40: 791-6. PMID 6227312 DOI: 10.1001/Archneur.1983.04050120041005  0.321
1982 Josiassen RC, Shagass C, Roemer RA, Ercegovac DV, Straumanis JJ. Somatosensory evoked potential changes with a selective attention task. Psychophysiology. 19: 146-59. PMID 7071293 DOI: 10.1111/J.1469-8986.1982.Tb02536.X  0.686
1982 Josiassen RC, Curry L, Roemer RA, DeBease C, Mancall EL. Patterns of intellectual deficit in Huntington's disease. Journal of Clinical Neuropsychology. 4: 173-83. PMID 6213679 DOI: 10.1080/01688638208401127  0.589
1982 Josiassen RC, Shagass C, Mancall EL, Roemer RA. Somatosensory evoked potentials in Huntington's disease. Electroencephalography and Clinical Neurophysiology. 54: 483-93. PMID 6181971 DOI: 10.1016/0013-4694(82)90033-5  0.748
1981 Shagass C, Roemer RA, Straumanis JJ, Josiassen RC. Intelligence as a factor in evoked potential studies of psychopathology. I. Comparison of low and high IQ subjects. Biological Psychiatry. 16: 1007-30. PMID 7349616  0.735
1981 Josiassen RC, Shagass C, Roemer RA, Straumanis JJ. The attention-related somatosensory evoked potential late positive wave in psychiatric patients. Psychiatry Research. 5: 147-55. PMID 6945610 DOI: 10.1016/0165-1781(81)90045-7  0.742
Show low-probability matches.